Esophageal lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age = 18 years, gender is not limited; 2. Esophageal protruding lesion necessitating EUS probe examination; 3. Willing to actively participate and adhere to the experimental protocol, accept regular follow-up examinations as planned, and provide informed consent.
Exclusion criteria
Exclusion criteria: 1. Those with severe heart disease (NYHA classification = class ?), lung disease or a pacemaker implant, who cannot tolerate upper gastrointestinal endoscopy; 2. Those with coagulation disorders (prothrombin time = 18 s), those with hemorrhagic diseases, and those taking oral anticoagulants; 3. Patients with corrosive esophagitis; 4. Those who cannot tolerate painless endoscopic ultrasound; 5. Those with acute severe throat diseases, unable to insert an endoscope; 6. Women who are pregnant or lactating during screening; 7. Those who have participated in other clinical trials within three months before the trial. 8. Other situations deemed unsuitable for selection by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endoscopic ultrasound image quality;Routine blood analysis;Inflammatory factors;Liver function;Kidney function;Electrolyte;Blood fat;Urine routine test;Stool routine test;Adverse events during endoscopic ultrasound; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thermosensitive couplant/saline dosage;Time consuming of endoscopic ultrasound;Adverse events after endoscopic ultrasound; | — |
Countries
China
Contacts
Second Affiliated Hospital of Army Medical University